[Immunosuppression in kidney transplantation]
- PMID: 18457319
- DOI: 10.1016/j.anuro.2007.08.006
[Immunosuppression in kidney transplantation]
Abstract
Kidney transplantation has become the treatment of choice in end-stage chronic renal failure since it significantly improves both the quality of life and the life duration of affected patients, when compared with dialysis. Some of these better results that were observed over the last thirty years are obviously due to significant improvements in the quality of immunosuppression. In the first part of this chapter, the allo-immune response is schematically described regarding the various signals. Then, the mechanisms of action of the available or future immunosuppressive therapies are described in the same order as the allo-immune response. In the third part, the various combinations of immunosuppressive regimens are presented from a historical perspective, outlining not only the positive aspects of each class of drugs but also their side effects and consequences on the practical use of immunosuppression over time. Finally, a brief review of current and future perspectives regarding the improvement of both efficacy and tolerability of immunosuppression in kidney transplantation is presented.
Similar articles
-
Current trends in immunosuppression.Nefrologia. 2006;26 Suppl 2:3-8. Nefrologia. 2006. PMID: 17937629 Review. English, Spanish. No abstract available.
-
Evolutionary experience with immunosuppression in pediatric intestinal transplantation.J Pediatr Surg. 2005 Jan;40(1):274-9; discussion 279-80. doi: 10.1016/j.jpedsurg.2004.09.020. J Pediatr Surg. 2005. PMID: 15868597
-
Induction immunosuppression in kidney transplant recipients older than 60 years of age : safety and efficacy of ATGAM, OKT3 and Simulect.Drugs Aging. 2004;21(11):747-56. doi: 10.2165/00002512-200421110-00005. Drugs Aging. 2004. PMID: 15323580
-
[Immunosuppressors].Nefrologia. 2008;28 Suppl 5:21-5. Nefrologia. 2008. PMID: 18847416 Review. Spanish.
-
Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.Transplant Proc. 2001 Nov-Dec;33(7-8):3334-6. doi: 10.1016/s0041-1345(01)02435-6. Transplant Proc. 2001. PMID: 11750425 Clinical Trial. No abstract available.
Cited by
-
Systematic Review of Calcineurin Inhibitors and Incidence of Skin Malignancies after Kidney Transplantation in Adult Patients: A Study of 309,551 Cases.Curr Oncol. 2023 Jun 13;30(6):5727-5737. doi: 10.3390/curroncol30060430. Curr Oncol. 2023. PMID: 37366913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical